September 28, 2015
BREAKING MS NEWS: Genentech’s Ocrelizumab First Investigational Medicine to Show Efficacy in People with Primary Progressive Multiple Sclerosis in Large Phase III Study
- /
- /
- /
Phase III study meets primary endpoint in debilitating form of multiple sclerosis with no approved treatments Ocrelizumab is the first…
